Search - tctmd.com

Displaying 81 - 100 of 251

Sort: Relevancy | Date

Sapien M3: Device Attributes, Implant Procedure, and Early Results

Presentation TCT 2018

Sapien M3: Device Attributes, Implant Procedure, and Early Results

Presenter: Michael J. Mack, David W.M. Muller, Raj Makkar

September 24, 2018

SAPIEN M3 Transcatheter Mitral Valve Replacement System: 30-Day Outcomes From the US Early Feasibility Study

Presentation TCT 2018

SAPIEN M3 Transcatheter Mitral Valve Replacement System: 30-Day Outcomes From the US Early Feasibility Study

Presenter: Charles J. Davidson, Francesco Maisano, Raj Makkar

September 24, 2018

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Presentation TCT 2018

Long-Term Outcomes of LM PCI vs CABG: New Insights From the MAIN-COMPARE and IRIS-MAIN Registries

Presenter: Raj Makkar, Patrick W. Serruys, Duk-Woo Park

September 23, 2018

Ten-Year Outcomes of LM PCI: From the Fu-Wai Left Main Registry

Presentation TCT 2018

Ten-Year Outcomes of LM PCI: From the Fu-Wai Left Main Registry

Presenter: Raj Makkar, Patrick W. Serruys, Bo Xu

September 23, 2018

LM Stenting: New Insights From the DELTA-2 Registry

Presentation TCT 2018

LM Stenting: New Insights From the DELTA-2 Registry

Presenter: Raj Makkar, Patrick W. Serruys, Alaide Chieffo

September 23, 2018

Summary of All the LM PCI vs. CABG Meta-Analyses: Take-Home Messages

Presentation TCT 2018

Summary of All the LM PCI vs. CABG Meta-Analyses: Take-Home Messages

Presenter: Raj Makkar, Patrick W. Serruys, Stuart J. Head

September 23, 2018

First Presentation of the 4-Year EXCEL Outcomes

Presentation TCT 2018

First Presentation of the 4-Year EXCEL Outcomes

Presenter: Raj Makkar, Patrick W. Serruys, Gregg W. Stone

September 23, 2018

Secondary Mitral Regurgitation With Severely Reduced LVEF

Presentation TCT 2018

Secondary Mitral Regurgitation With Severely Reduced LVEF

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Bicuspid Aortic Stenosis: How To Treat

Presentation TCT 2018

Bicuspid Aortic Stenosis: How To Treat

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Low Surgical Risk Aortic Stenosis In The Us: The Patient Really Wants TAVR

Presentation TCT 2018

Low Surgical Risk Aortic Stenosis In The Us: The Patient Really Wants TAVR

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Raj Makkar

June 22, 2018

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

November 30, 2017

The Clinical Relevance of Valve Leaflet Thickening after TAVR

Presentation TCT 2017

The Clinical Relevance of Valve Leaflet Thickening after TAVR

Presenter: Raj Makkar

November 01, 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presentation TCT 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presenter: Raj Makkar

November 01, 2017

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Presentation TCT 2017

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Presenter: Gilles Dreyfus, Sanjay Kaul, Raj Makkar

November 01, 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care – PRO!

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Presenter: Adrian P. Banning, Ted Feldman, Raj Makkar

November 01, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.